Connection

Philip Privitera to Propranolol

This is a "connection" page, showing publications Philip Privitera has written about Propranolol.
Connection Strength

0.371
  1. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol. J Pharmacol Exp Ther. 1988 Aug; 246(2):529-33.
    View in: PubMed
    Score: 0.073
  2. Site and mechanism of the centrally mediated hypotensive action of propranolol. J Pharmacol Exp Ther. 1985 Oct; 235(1):66-70.
    View in: PubMed
    Score: 0.060
  3. Cerebroventricular propranolol elevates cerebrospinal fluid norepinephrine and lowers blood pressure. Science. 1981 Aug 21; 213(4510):911-3.
    View in: PubMed
    Score: 0.045
  4. Effects of centrally administered propranolol on plasma renin activity, plasma norepinephrine and arterial pressure. Eur J Pharmacol. 1979 Feb 15; 54(1-2):51-60.
    View in: PubMed
    Score: 0.038
  5. Studies on the contribution of active metabolites to the anticonvulsant effects of propranolol. Eur J Pharmacol. 1977 Mar 07; 42(1):39-46.
    View in: PubMed
    Score: 0.033
  6. Quantitative determination of propranolol, propranolol glycol and N-desisopropylpropranolol in brain tissue by electron capture gas chromatography. J Chromatogr. 1976 Jul 21; 123(1):185-92.
    View in: PubMed
    Score: 0.032
  7. Stereochemistry of tissue distribution of racemic propranolol in the dog. Chirality. 1989; 1(3):192-6.
    View in: PubMed
    Score: 0.019
  8. Time course of development of the antihypertensive effect of propranolol. Hypertension. 1983 Nov-Dec; 5(6):852-7.
    View in: PubMed
    Score: 0.013
  9. Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response. J Pharmacol Exp Ther. 1983 Aug; 226(2):324-9.
    View in: PubMed
    Score: 0.013
  10. Cardiovascular effects of a 4'-methylthio analog of propranolol. J Pharmacol Exp Ther. 1981 Dec; 219(3):685-90.
    View in: PubMed
    Score: 0.012
  11. The importance of stable isotope labelled drugs in clinical pharmacology: with illustrations from studies on the disposition of propranolol and nortriptyline in man. South Med J. 1974 Aug; 67(8):990-1002.
    View in: PubMed
    Score: 0.007
  12. Cardiovascular actions of a new metabolite of propranolol: isopropylamine. J Pharmacol Exp Ther. 1974 Jun; 189(3):626-32.
    View in: PubMed
    Score: 0.007
  13. Central nervous system effects and metabolic disposition of a glycol metabolite of propranolol. J Pharmacol Exp Ther. 1974 Jan; 188(1):86-92.
    View in: PubMed
    Score: 0.007
  14. The psychopharmacological effects of a new metabolite of propranolol. Adv Biochem Psychopharmacol. 1973; 7:107-12.
    View in: PubMed
    Score: 0.006
  15. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197). J Pharmacol Exp Ther. 1971 Mar; 176(3):655-61.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.